Inhibition of MRTF activation as a clinically achievable anti-fibrotic mechanism for pirfenidone
Hsiao‐Yen Ma(Gene Therapy Laboratory), Ning Ding(Shanghai Jiao Tong University)
Cited by 23
Related Papers
LOXL4, but not LOXL2, is the critical determinant of pathological collagen cross-linking and fibrosis in the lung
|Science Advances|2023|48
Parallel 28: Liver Fibrosis: Basic and Translational
|Hepatology|2015|0